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Abstract. This  work deals  with  coupling  Clinical  Decision 
Support  System  (CDSS)  with  Computerized  Prescriber 
Order  Entry  (CPOE)  and  their  dynamic  plugging  in  the 
medical  Workflow Management  System (WfMS).  First,  in 
this  paper we argue some existing  CDSS representative of 
the state of the art in order to emphasize their inability to 
deal  with  coupling  with  CPOE  and  medical  WfMS.  The 
multi-agent  technology  is  at  the  basis  of  our  proposition 
since  (i)  it  provides  natural  abstractions  to  deal  with 
distribution,  heterogeneity  and  autonomy  which  are 
inherent to the previous systems (CDSS, CPOE and medical 
WfMS),  and  (ii)  it  introduces  powerful  concepts  such  as 
organizations,  goals  and roles  useful  to describe  in details 
the  coordination  of  the  different  components  involved  in 
these systems.  In this paper, we also propose a Multi-Agent 
System (MAS) to support  the coupling  CDSS with CPOE. 
Finally, we show how we integrate the proposed MAS in the 
medical  workflow management  system which is also based 
on collaborating agents.  
Keywords:  Clinical  Decision  Support  System,  Computerized  
Prescriber Order Entry, Multi-agent Technology and Medical  
Workflow management System. 
I.  INTRODUCTION
The purpose of Clinical  Decision Support  System (or 
CDSS  for  short)  is  to  assist  health  professionals  with 
decision  making tasks,  as  determining  diagnosis or 
analysis of patient data [1]. 
In spite of the growing multiplicity of CDSS and their 
effectiveness certified in the decision making tasks at the 
time and the location of care,  the state of the art  of the 
existing  CDSS ([2-6])  emphasizes  four  main  challenges 
that require to be resolved. The first challenge is that the 
clinical  data  that  must  be  entered  is  already  contained 
elsewhere in a digital form in that hospital’s system, and 
some  CDSSs  (alert  system,  drug-drug  detection  system, 
medicinal  errors  prevention  system, etc.)  are  not  able to 
access and exploit this information. The second challenge 
concerns  the  appropriate  decision  making  by the  health 
professionals to a patient. Indeed, the majority of existing 
CDSS exploit only the list of the actives prescripts of the 
patient,  which  is  compared  with  a  frozen  source  of 
knowledge fulfilled under form of mapping table. In others 
terms, they do not take into account the clinical context of 
the  patient.  A  such  CDSS  must  consider  several 
information’s such as patient’s symptoms, medical history, 
family  history and  genetics.  It  needed  to  interact  with 
others clinical data sources such as patient administrative 
data,  physio-pathologic  profile,  biological  analysis  data, 
etc.  The  third  challenge  is  that  the  CDSS is  often  not 
connected  to  Computerized  Prescriber  Order  Entry 
(CPOE)  which  assists  the  doctor  in  preparing  the 
prescripts. 
The last challenge concerns the integration issue of the 
CDSS and  CPOE in  the medical  workflow management 
system.  In fact, often the clinical user must stop clinical 
process  on  the  current  system,  switch  to  the  CDSS  or 
CPOE, and reenter data necessary into the CDSS that may 
already exist in another healthcare system.
An obvious example of clinical workflow is the patient 
care  in  an  accident  case.  In  this  case,  various  health 
professionals  such  as  the  doctors,  the  nurses,  the 
pharmacists,  must  cooperate,  synchronize  their 
intervention processes, share the access to the clinical data 
sources  and  use the  CDSS,  the  CPOE without  stop  the 
clinical  process to act in a coherent  way and in order to 
give care to the patient. 
Giving  the  previous observations,  the  problem being 
addressed in  this paper  can be resumed according to the 
following  two questions:  “how to design  and  develop a 
CDSS which considers the previous challenges? How do 
we integrate the CDSS and CPOE in the medical workflow 
management system?
The contribution  of the paper  is  to provide a  Multi-
Agent System (MAS) to support the coupling CDSS with 
CPOE. Then,  it  explains  how we integrate  the proposed 
MAS in the medical Workflow management system. 
Our approach is based on the following principles:
- The  use  of  multi-agent  technology,  which  provides 
relevant high-level features to design and implement 
CDSS,  CPOE  and  clinical  workflow  management 
system.  Indeed,  Agent  technology  provides  natural 
abstractions  to  deal  with  autonomy,  distribution, 
heterogeneity and  cooperation  which  are inherent  to 
the previous systems,
- A  coordination  model  based  on  organizational 
dimension. A good coordination model among clinical 
workflow  components  requires  an  organizational 
model which attributes roles to each component  and 
constraints their interactions, 
- An engineering perspective, which takes into account 
the  existing  standards.  It  defines  an  architecture 
which is compliant  with the WfMC reference model 
[7] and the involved agents communicate among them 
using  the  FIPA-ACL standard  [8].  This  compliance 
allows a very large usability and interoperability of the 
solution.
The remainder  of this  paper  is organized  as follows. 
Section 2 exposes some related works regarding the design 
and the development of CDSS in order to underline their 
inability  to  deal  with  the  challenges  as  mentioned 
previously.  Section  3  presents  our  Multi-Agent  System 
(MAS)  for  supporting  the  coupling  CDSS  with  CPOE. 
This section first justifies the interest of use of multi-agent 
technology to design  and  develop the CDSS, CPOE and 
WfMS systems. It  exposes then our proposed multi-agent 
system. Section 4 shows how we integrate dynamically the 
proposed  MAS  in  the  medical  workflow  management 
system  and  presents  an  organizational  model  based  on 
message methodology [9] that  structures  the interactions 
between agents and highlights  the coordination at  macro 
level.  Section  5  concludes  the  paper  and  gives  some 
perspectives.
II. RELATED WORKS
Regarding  the design  and development of CDSS, the 
use of agent technology is not new, and several works have 
been proposed in the literature ([2-6]). 
[2] defends the interest of using agents to extend the 
medical  expert  systems. Indeed,  according  to the [2] the 
agents  can  resolve  some  issues  by  checking  several 
conditions  that  could  be  ignored  by humans  and  as  a 
consequence  the  elimination  of some mistakes  from the 
physicians’ decisions. More precisely, [2] proposes a new 
cooperative medical diagnosis system called “Contract Net 
Based Medical  Diagnosis System”.  This  latter  owns two 
specific features namely the autonomy and the flexibility 
during the treatment of medical diagnosis problems. The 
proposed system in  [2]  does not  support  the  interaction 
either with the CPOE or with the medical WfMS.
[3]  proposes  a  CDSS called  “SAPHIRE”.  The  main 
purpose  of  this  system  is  to  support  the  definition, 
deploying and performing clinical guidelines to a patient. 
It is composed of a set of collaborating agents running in a 
heterogeneous  distributed  environment.   SAPHIRE  has 
two main advantages. Firstly, it proposes a specific agent 
called  “EHR”  agent”  that  is  responsible  to  access  and 
extract  clinical  data  from  the  Electronic  Healthcare. 
Secondly, it supports the interaction with several modules 
in the clinical workflow.  The main limits of this work are 
the  following:  (i)  the  non  possibility to couple with  the 
CPOE  and  (ii)  the  use  of agent  only for  the  design  of 
CDSS.
[4] provides a framework based on multi-agent system 
paradigm  in  order  to  build  a  comprehensive  clinical 
decision applications aimed at various medical conditions. 
This work has not addressed the coupling issue with the 
healthcare  systems  such  as  CPOE,  clinical  workflow 
system, etc.
[5]  proposes  a  multi-agent  system called  IMASC to 
assist  physicians  and  other  health  professionals  with 
decision making tasks.  In spite of the system is powerful, 
it does not support the previous challenges, as mentioned 
in introduction, and namely the coupling with CPOE and 
the  dynamic  integration  in  the  medical  workflow 
management system.
[6] provides a prototype called MET3 which aims at 
data  collection,  diagnosis  formulation  and  treatment 
planning.  MET3  is  based  on  multi-agent  technology.  It 
supports the interoperability issue since it runs on different 
platforms.  It  is  also  capable  to  interact  which  hospital 
information  systems  and  particularly  with  an  electronic 
patient  record  system  via  HL7  messages  to  provide 
realistic integration with existing healthcare systems. 
Our  work  differs  from the  previous  works  on  three 
points. First, it addresses the coupling CDSS with  CPOE 
aspect  which  has  not  been  addressed  in  the  previous 
works.  Second,  the  proposed  architecture  for  medical 
Workflow  management  system  is  compliant  with  the 
Workflow Management Coalition reference model. Third, 
to  the  best  of our  knowledge,  the  dynamic  plugging  of 
CDSS and CPOE in the medical  Workflow management 
system  through  the  agent  technology  has  not  been 
addressed. Thus, we believe that our solution is currently 
unique in  trying  to take into account  the agents  to deal 
with  coupling  CDSS  with  CPOE  and  their  dynamic 
integration in the medical WfMS. 
III. A MULTI-AGENT SYSTEM FOR COUPLING CDSS WITH 
CPOE
This  section  is  devoted  to  the  motivation  for  using 
multi-agent  technology  and  presents  our  multi-agent 
system for coupling CDSS with CPOE.
A. Motivation for using multi-agent technology  
The  multi-agent  technology can  help  the  design  and 
the  development  of CDSS,  CPOE and  clinical  workflow 
system thanks to the following high-level properties [10]:
- Autonomy of  agents  eases  the  cooperation  since  it 
avoids regular and direct interventions of the systems: 
the medical  information system or clinical  workflow 
management  system can be agentified to support the 
cooperation and provides needed information to each 
health  professional.  Agents can also play the role of 
interface between the actors and the system (filtering 
and notification of events, providing relevant views of 
the whole system and its evolution).
- Natural abstractions to deal with cooperation.  A lot of 
sophisticated  protocols  like  Contract-Net  Protocols 
and Negotiation mechanisms are available and could 
be  used  to  coordinate  processes  ([11]  [12]).  Agent 
technology also  provides  organizational  concepts  to 
abstract  and  structure  a  system  as  a  computational 
community made of groups, roles and interaction.
- Pro-active  and  reactive  attitudes  of agents  ease  the 
control and enactment of clinical processes as well as 
reactions to events, and hence the synchronization of 
related activities.  Being able to exhibit  goal-directed 
behaviour, agents can take the initiative to select and 
engage cooperation with others actors. 
- Social  abilities  of  agents  also  ease  the  cooperation 
needed  to  enact  complex  clinical  workflows and  to 
provide  an  abstraction  to  high-level  concepts  like 
commitments, reputations and so on.
B. The proposed MAS for coupling CDSS with CPOE 
In order to support the coupling CDSS with CPOE, we 
propose a Multi-Agent  System (MAS) where each agent 
plays a specific role or function and exploits one or several 
clinical  data  sources.  More precisely,  the architecture  of 
our  MAS is  organized  around  five clinical  data  sources 
and ten specialized agent. Let us detail the role/function of 
each agent.  
The communication between agents is assured thanks 
to the FIPA-ACL language [8].
The Information Collection Agent (ICA) is responsible 
to  extract  information’s  from  two clinical  data  sources 
(patient administrative data and physio-pathologic profile) 
such  as  name,  type,  date  of birth,  service,  weight,  size, 
diagnosis,  allergy,  against  indications,  situations  at  risk 
and  so  on.  It  is  to  signal  that  these  information’s  are 
managed by a medical information system and they can be 
also exploited by the others systems like CDSS and CPOE 
in our context. In this case, this agent answers to the two 
first  challenges  as  mentioned  in  introduction  i.e.  we 
haven’t need to enter these information’s again. 
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Figure 1. A MAS for Coupling CDSS with CPOE
The Drug Selection Agent (DSA) cooperates with the 
ICA  and  the  Pharmacy  Stock  Checker  Agent  (PSCA) 
when selecting the drug form data bank of drugs.  The role 
of the PSCA is to verify from the drug repository if the 
selected  drug  is  available  or  in  rupture  of  supply.  In 
unavailability case, it  recommends to substitute the drug 
by another  generic.   The  DSA  also  interacts  with  the 
Administration  Mode  Selection  Agent  (AMSA)  who 
provides  relevant  information’s  regarding  administration 
mode, for each selected drug, such as unit of catch, dosage 
by default,  and  borders  dosage  by catch,  a  day and  by 
kilogram of weight. To do this, it enters in connection with 
the Drug Errors Detection Agent.
The  Prescription Analyzer  Agent  (PAA) triggers  two 
agents to analyze and validate the current prescription: the 
Drug Errors Detection Agent (DEDA) and the Drug-Drug 
Interaction Detection Agent (DDIDA). More precisely, the 
Drug Errors  Detection Agent  (DEDA) interacts with the 
AMSA and DDIDA in order to verify if there is an error 
such  as  error  of  dose,  error  of  choice  (i.e.  a  drug  not 
conforms to the reference), drug-drug interaction or error 
of administration  mode and  so on.  In  the  literature,  we 
distinguish  two types  of  medicinal  errors.  A  medicinal 
error  is  said  potential  if  it  was  discerned  before  drug 
arrives up to the patient.  It  is said proved to be if it was 
discerned  after  the  catch  of drug  by the  patient.  In  our 
work, we support the first type of medicinal error in order 
to guarantee a well service to the patient.
 The Drug-Drug Interaction Detection Agent (DDIDA) 
consists  in  proving  if  the  association  of medicaments  is 
likely to  cause  undesirable  effects,  allergies,  etc.  To  do 
this, it interacts with the Drug Errors Detection Agent and 
exploits the biological analysis data source.
The Protocols Recording Agent (PRA) stores all types 
of  prescripts  as  protocols  which  will  be  then  
called  by  their  title.  As  a  consequence,  the  time  of 
prescript becomes considerably reduced.
The Information Delivery Agent (IDA) is responsible 
to deliver  the information  to the concerned  clinical  user 
like the chemist, the nurse, etc.
The  Therapeutic  File  Agent  (TFA)  preserves  the 
validated  prescription  as  archived  files  in  order  to  be 
exploited in the future. 
IV.  DYNAMIC PLUGGING OF CDSS AND CPOE IN THE 
MEDICAL WORKFLOW MANAGEMENT SYSTEM
The  purpose  of  this  section  is  (i)  to  rethink  the 
reference model of a WfMS with agent technology in order 
to deal  with medical  processes and  (ii)  to show how we 
integrate the  MAS that supports the coupling CDSS with 
COPE in the new architecture of WfMS. 
A. The reference architecture of a WfMS
According  to  this  architecture,  a  WfMS  includes  a 
Workflow  Enactment  Service  (WES)  and  supports  the 
following interfaces (see figure 2) [7]: 
- Interface 1 with Process Definition,
- Interface 2 with Workflow Client Applications, 
- Interface 3 with Invoked Applications, 
- Interface 4 with others WESs, 
- Interface 5 with Administration and Monitoring.
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Figure 2. The reference model of a WfMS [7]
Two  main  components  of  this  architecture  are  the 
WES and Interface 4. The aim of the WES, on which one 
imposes  no  constraints  upon  its  internal  structure,  is  to 
manage  the  execution  of  one  or  several  instances  of 
processes while the aim of Interface 4 is to connect WfMS 
together  in  order  to  share  the  execution  of a  workflow 
process between different WESs of different organizations.
However,  this  reference  architecture  is  inadequate  in 
the clinical context since the WES must not only execute 
clinical  processes but also must  mix different  concurrent 
activities  including  clinical  decision  making,  analyzing 
and  validation  of prescription,  etc.  In  others  words,  the 
WES need to cooperate with CDSS and CPOE. 
B. Revisiting the WES with agents and dynamic  
plugging of CDSS and CPOE
Figure  3  explains  how  we  have  rethought  the 
Workflow  Enactment  Service  using  agents.  This 
architecture includes (i) as many Clinical Workflow agents 
as  running  clinical  process  instances,  (ii)  an  Agent 
Manager responsible for these Clinical Workflow Agents, 
(iii)  a  Connector  Agent  that  interacts  with  CDSS  and 
CPOE specialized respectively in clinical decision making 
and  prescription  elaborating,  and,  (iv)  a  new interface, 
Interface  6,  to  support  the  communication  between  a 
Connector Agent and the proposed MAS.
Regarding  clinical  Workflow Agents,  the  idea  is  to 
implement  each  clinical  process  instance  (stored  in  the 
Clinical Processes database, CP) as a software process, and 
to encapsulate this instance within an (pro-) active agent. 
Such  a  clinical  Workflow  Agent  includes  a  workflow 
engine  that,  as  and  when  the  clinical  process  instance 
progresses,  reads  the  CP schema definition  (specified in 
XML  schema),  and  triggers  the  action(s)  to  be  done 
according  to  its  current  state.  This  clinical  Workflow 
Agent supports interface 3 with the applications that are to 
be used to perform pieces of work associated to process’ 
tasks. 
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Management System
The Agent Manager controls and monitors the running 
of clinical Workflow Agents:
Upon a request for a new instance of a clinical process, 
the  agent  manager  creates  a  new  instance  of  the 
corresponding clinical process agent schema, initializes its 
parameters  according  to  the  context,  and  launches  the 
running of its workflow engine.
It  ensures the persistency of clinical  Workflow Agents 
that  execute long-term  clinical  processes extending  to a 
long time in which task performances are interleaved with 
periods of inactivity. 
It  coordinates clinical Workflow Agents in their use of 
shared resources. 
It assumes interfaces 1, 2 and 5 of the WfMS with the 
environment.
The  role  of  the  Connector  Agent  is  to  help  clinical 
Workflow Agents  to  find  the  clinical  information  they 
need. More precisely, the Connector Agent interacts with 
CDSS  specialized  in  clinical  decision  making.  This 
requires defining a new interface, Interface 6 that supports 
the communication between a Connector Agent, the CDSS 
and  the  COPE.  Interface  4 of the  reference architecture 
cannot  be used  for  such  a  communication  since  it  only 
supports  the  execution  of  a  clinical  process  between 
different workflow engines.
In  our  proposition,  we  consider  coordination  as  a 
specific component  when designing  and  implementing  a 
clinical  Workflow,  and  consequently,  we  separate 
coordination  activities  from clinical  processes execution. 
That  is  why  we  introduced  mediation  infrastructure, 
gathering  the  CDSS  and  COPE.  This  infrastructure  of 
course  independent  of  the  WES,  and  is  dynamically 
plugged to it only when it is necessary. 
The  standard  FIPA-ACL (Foundations  of  Intelligent 
Physical Agents-Agent Communication Language [8]), is 
used  to  support  the  interaction,  through  message 
exchange,  between  the  agents  inside  the  architecture  of 
WfMS. FIPA-ACL offers a convenient set of performatives 
for  supporting  the  cooperation  between  agents  (e.g. 
inform, ask, propose, agree, cfp,...).  Moreover, FPA-ACL 
supports  exchange  messages  between  heterogeneous 
agents since (i) the language used to specify the message is 
free and (ii) a message can refer to ontology. This is very 
interesting  in  the  context  of  inter  organization  clinical 
processes  since  ontology can  be used  to  solve semantic 
interoperability problems.
C. An  organizational  model  based  on  message  
methodology  for  ruling  the  interaction  between  the  
clinical workflow components
Our organizational  model (see figure 4) is organized 
around the following components:
- Three organizations  represented by triangles: 
- Ten agents represented by circles :
- Nine tasks represented by polygons: 
- Three roles represented by moon:
- and three goals represented by double circles:
For clarity reason of the organizational model we give 
only the  tasks,  goals  and  roles  for  three  agents  (Agent 
Manager and Drug-Drug Interaction Detection Agent and 
Prescription Analyzer Agent.
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Figure  4.  An  organizational  model  for  structuring  the  communication 
between CDSS, CPOE and clinical WfMS
Let us detail how each organization operates. 
The  Clinical  Workflow  Management  Organization 
enables one or several clinical workflow agents to interact 
with their connector to which make a clinical decision or 
elaborate a validated prescription.
The  Computerized  Prescriber  Order  Entry 
Organization enables the Prescription Analyzer  Agent  to 
interact  at  the  first  step  with  the  drug  selecting  Agent. 
This  latter  interacts  in  its  turn  with  the  information 
collection  agent,  pharmacy  stock  checker  Agent  and 
Administration mode selection agent. At the second time, 
the  Prescription  Analyzer  Agent  connects  to  the  Drug-
Drug  interaction  Detection  Agent  and  Drug  Errors 
Detection Agent to analyze the current prescription. After 
the validation, it offers the following services thanks to the 
three agents: Information delivery, protocols recording and 
therapeutic file creation.
The  Clinical  Decision  Support  Organization  enables 
the  drug  errors  detection  and  drug-drug  interaction 
detection agents to enter in connection with the Connector 
Agent or the Prescription Analyzer Agent in order to give 
respectively help to the clinical user or assist the doctor to 
validate his prescription. This organization involves only 
those two agents.
V. CONCLUSION
This paper has dealt with  coupling CDSS with CPOE 
and  their  dynamic  plugging  in  the  medical  Workflow 
Management  System. More precisely, it  has presented in 
the one hand, a multi-agent system allowing the coupling 
CDSS with CPOE.  In the other hand, it has presented an 
architecture of clinical WfMS which revisits the reference 
model  defined  by the  WfMC  in  terms  of  collaborating 
agents. Some of these agents implement clinical processes, 
while others are dedicated to the CDSS and CPOE.
The  idea  defended  in  this  paper  is  that  the  agent 
technology is appropriate to face the coupling CDSS with 
CPOE  and  their  dynamic  integration  in  the  clinical 
WfMS. Several reasons motivate this idea. 
Firstly,  the  agent  technology is  appropriate  to model 
clinical processes since it provides natural  abstractions to 
deal  with  distribution,  heterogeneity  and  autonomy that 
are inherent to clinical processes.  
Secondly,  the  organizational  dimension  which  is 
inherent  to  multi-agent  systems  [9],  is  fundamental  to 
highlight  the  coordination  of  the  different  components 
involved in the three systems (CDSS, CPOE and clinical 
WfMS)  under  consideration  by  clearly  separating  the 
macro-level  (coordination)  from the  micro-level  (agent). 
Thus,  the  internal  architecture  of  the  agents  may  be 
thought  and  implemented  independently  from  their 
coordination.
As  future  work,  we  plan  (i)  to  study  in  depth  the 
behavior of all  agents involved in the CDSS, CPOE and 
WfMS systems, (ii) to formalize and build the knowledge’s 
used  by  the  agents  in  order  to  resolve  the  semantic 
conflicts,  (iii)  to implement  these agents  using  the  Jade 
[13] (Java Agent Development Framework) platform that 
offers  the  possibility to  simulate  the  execution  of these 
agents in autonomic way and in distributed mode and (iv) 
to evaluate the proposed tool according  to the  three key 
criteria: scalability, openness and efficiency.
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